Proactive Investors - Run By Investors For Investors

Orgenesis subsidiary MaSTherCell Global expanding into the US

Orgenesis Inc (NASDAQ:ORGS) subsidiary MaSTherCell Global CEO Derran Head tells Proactive Investors MaSTherCell is expanding into the US and building a new 30,000-square-foot manufacturing facility in Houston.

The Germantown, Maryland-based company’s subsidiary MaSTherCell Global is a leading cell and gene therapy global contract development and manufacturing organization, or CDMO.

 
View full ORGS profile View Profile

Orgenesis Timeline

Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use